• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外影响溶解的肝核受体 - 3,5,3'-三碘甲状腺原氨酸复合物稳定性的物理化学因素

Physiochemical factors influencing the stability of solubilized liver nuclear receptor-3,5,3'-triiodothyronine complex in vitro.

作者信息

Brtko J, Knopp J, DeGroot L J

机构信息

Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava.

出版信息

Endocrinol Exp. 1987 Dec;21(4):251-6.

PMID:3501978
Abstract

Nuclear acidic protein fraction containing saturable receptors for thyroid hormones was prepared from purified rat liver nuclei by extraction with 0.3 mol l-1 KCl. The inhibitory effect of an increasing ionic strength on the 3,5,3'-triiodothyronine (T3) binding to receptors at pH 8.0 for 2 h and tested up to 2.0 mol l-1 KCl was confirmed. The nuclear receptor-T3 complex was found resistant to the effect of a higher ionic strength up to 1 mol l-1 KCl when subsequently incubated at pH 8.0 for 1 h. In addition, a rapid dissociation of the receptor-T3 complex at alkaline pH in the order of 10.5 greater than 10.0 greater than 9.0 greater than 8.0 was re-examined. The effect of ATP ranging from 0.05 mmol l-1 to 1.0 mmol l-1 on the stability of the receptor-T3 complex at pH 8.0 was also studied. The experiments were conducted in the presence of 25 mmol l-1 Na2HPO4 in order to suppress the effect of the phosphate groups of ATP molecule by inorganic phosphate. The data confirmed that the concentration of ATP starting from 0.05 mmol l-1 may cause the dissociation of nuclear receptor-T3 complex in vitro.

摘要

通过用0.3 mol l-1 KCl提取,从纯化的大鼠肝细胞核中制备了含有甲状腺激素饱和受体的核酸性蛋白组分。证实了离子强度增加对pH 8.0下3,5,3'-三碘甲状腺原氨酸(T3)与受体结合2小时的抑制作用,并测试至2.0 mol l-1 KCl。当随后在pH 8.0下孵育1小时时,发现核受体-T3复合物在高达1 mol l-1 KCl的较高离子强度下具有抗性。此外,重新研究了受体-T3复合物在碱性pH下以10.5大于10.0大于9.0大于8.0的顺序快速解离的情况。还研究了0.05 mmol l-1至1.0 mmol l-1的ATP对pH 8.0下受体-T3复合物稳定性的影响。实验在25 mmol l-1 Na2HPO4存在下进行,以抑制无机磷酸对ATP分子磷酸基团的影响。数据证实,从0.05 mmol l-1开始的ATP浓度可能导致体外核受体-T3复合物的解离。

相似文献

1
Physiochemical factors influencing the stability of solubilized liver nuclear receptor-3,5,3'-triiodothyronine complex in vitro.体外影响溶解的肝核受体 - 3,5,3'-三碘甲状腺原氨酸复合物稳定性的物理化学因素
Endocrinol Exp. 1987 Dec;21(4):251-6.
2
Modulation of nuclear receptor affinity for 3,5,3'-triiodothyronine by nucleotide in vitro.
Endocrinol Exp. 1985 Dec;19(4):245-51.
3
Study of the role of tryptophanyl and arginyl residues in the specific binding of 3,5,3'-triiodothyronine to rat liver nuclear receptors.
Endocrinol Exp. 1989 Dec;23(4):259-67.
4
Effects of adenosine triphosphate and alkaline phosphatase on solubilized 3,5,3'-triiodothyronine-binding activity.
Endocrinology. 1988 Sep;123(3):1245-52. doi: 10.1210/endo-123-3-1245.
5
Rat liver nuclear receptors for thyroid hormone: binding characteristics after stabilization and storage.
Folia Biol (Praha). 1993;39(2):69-77.
6
Thyroid hormone action: in vitro characterization of solubilized nuclear receptors from rat liver and cultured GH1 cells.甲状腺激素作用:大鼠肝脏和培养的GH1细胞中可溶性核受体的体外特性研究
J Clin Invest. 1974 Oct;54(4):853-65. doi: 10.1172/JCI107825.
7
Effect of protease inhibitors and substrates on 3,5,3'-triiodothyronine binding to rat liver nuclear receptors.
Endocr Regul. 1992 Sep;26(3):127-31.
8
Thyroid hormone binding sites in rat liver nuclear fraction.大鼠肝脏细胞核组分中的甲状腺激素结合位点
Endocrinol Exp. 1980 Sep;14(3):199-205.
9
Does amiodarone inhibit T3 binding to solubilized nuclear receptors in vitro?
Horm Metab Res. 1989 Sep;21(9):483-8. doi: 10.1055/s-2007-1009268.
10
An activator protein-1 (AP-1) response element on pro alpha1(l) collagen gene is necessary for thyroid hormone-induced inhibition of promoter activity in cardiac fibroblasts.原α1(I)型胶原基因上的活化蛋白-1(AP-1)反应元件是甲状腺激素诱导抑制心脏成纤维细胞启动子活性所必需的。
J Mol Cell Cardiol. 1998 Nov;30(11):2495-506. doi: 10.1006/jmcc.1998.0811.